Clinical impact of anti-thymocyte globulin on survival and graft-versus-host disease in patients undergoing human leukocyte antigen mismatched allogeneic stem cell transplantation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clinical impact of anti-thymocyte globulin on survival and graft-versus-host disease in patients undergoing human leukocyte antigen mismatched allogeneic stem cell transplantation

Published:2020-03-01 Issue:2 Volume:35 Page:429-437
ISSN:1226-3303
Container-title:The Korean Journal of Internal Medicine
language:en
Short-container-title:Korean J Intern Med

Author:

Kim Taeyun,Choi Yunsuk,Lee Je-Hwan,Park Silvia,Ahn Jae-Sook,Moon Joon-Ho,Shin Ho-Jin,Lee Won Sik,Kim Dajung,Lee Ho Sup

Publisher

Korean Association of Internal Medicine

Link

http://kjim.org/upload/kjim-2018-317.pdf

Reference26 articles.

1. Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: potential advantage of blood over marrow allografts [see comments]

2. Allogeneic Stem-Cell Transplantation — A T-Cell Balancing ACT

3. Anti-thymocyte globulins for post-transplant graft-versus-host disease prophylaxis—A systematic review and meta-analysis

4. Use of a five-agent GVHD prevention regimen in recipients of unrelated donor marrow

5. Antilymphocyte Globulin for Prevention of Chronic Graft-versus-Host Disease

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systematic review and meta-analysis of anti-thymocyte globulin dosage as a component of graft-versus-host disease prophylaxis;PLOS ONE;2023-04-18

2. The frequencies of lymphocyte subsets on “day 30″ correlate with the clinical outcome of pediatric hematopoietic stem cell transplantation;Immunology Letters;2023-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP